No Data
No Data
Mincab, Inphonoid, Astroscale Holdings, etc.
<186A> Astroscale Holdings Inc. Okada Mitsunobu's shareholding ratio -% -> 21.98% Reporting obligation start date: June 5, 2024 <4436> Mincab the Infonoid Co., Ltd. Norway Bank (Norges Bank) shareholding ratio 5.55% -> 4.50% Reporting obligation start date: June 5, 2024 <4576> De Western Ceraptex Research Institute Co., Ltd. With Partner Co., Ltd.
Including Manabi Aid and Commerce One Holdings, etc.
<184A> Gakumibaido Co., Ltd. & KP Partners Co., Ltd. shareholding ratio - → 24.39%, report obligation date May 28, 2024<184A> Gakumibaido Co., Ltd. Hirose, Shuichi shareholding ratio - → 38.90%, report obligation date May 28, 2024<3070> Amagasa Co., Ltd. Mirai Intellectual Property Technology Research Institute Co., Ltd. shareholding ratio 17.51% → 0.00%, report obligation date 202
Medical net, Bank of Innovation, etc.
<3645>Medical Net Co., Ltd. SBI Securities Stock Ownership Ratio 6.18% → 4.43% Reporting Obligation Date 2024/05/15 <4074>Raquel Co., Ltd. Tsutomu Kubo Stock Holding Ratio 47.79% → 44.50% Reporting Obligation Date 2024/05/16 <4393>Bank of Innovation Co., Ltd. SBI Securities Stock Holding Ratio 6.17% → 5.81% Reporting Obligation
Modalis, GRCS, etc. [5% rule for emerging markets]
<4175>COLY Co., Ltd. Daichi Sasaki Stock Ownership Ratio 7.50% → 7.20% Reporting Obligation Date 2023/09/08<4477>BASE Co., Ltd. Tsuruoka Yuta Stock Holding Ratio 16.15% → 17.20% Reporting Obligation Occurrence Date 2024/05/09 <4564>Oncotherapy Science Co., Ltd. Long Corridor Asset Management Limited (Long Corridor Asset M)
MODALIS THERAPEUTICS: Quarterly Report - 9th Quarter (2024/01/01 - 2024/03/31)
MODALIS THERAPEUTICS: Confirmation
No Data